Latest Content

NeuroSAFE Increases Erectile Function After Prostate Cancer Surgery

April 2nd 2025, 1:00pm

By Dr. Greg Shaw

Video

Use of NeuroSAFE to guide nerve sparing during robot-assisted radical prostatectomy improved patient-reported erectile function.

What Role Does MRD Play in Multiple Myeloma Treatment Decision Making?

April 1st 2025, 9:00pm

By Alex Biese

Article

Dr. Surbhi Sidana discussed the topic of minimal residual disease during the CURE Educated Patient® Multiple Myeloma Summit.

Raising Awareness of Financial Struggles Faced by AYA Cancer Survivors

April 1st 2025, 8:00pm

By Alison Silberman

Video

Adolescent and Young Adult Cancer Awareness Week sheds light on the financial hardships young cancer survivors face, including debt and limited assistance.

Dive Into March 2025 FDA Approvals Across Cancer Subtypes

April 1st 2025, 7:05pm

By Ryan Scott

Article

Here is a roundup of March 2025 U.S. FDA approvals across cancer subtypes, including prostate, bladder and gastrointestinal cancers.

What To Know About Having Radiation for Metastatic Prostate Cancer

April 1st 2025, 5:49pm

By Chester Freeman

Article

As a caregiver, I learned that CyberKnife radiation for metastatic prostate cancer comes with psychological and physical challenges.

First Patient Dosed With Annamycin and Cytarabine in Phase 3 AML Trial

April 1st 2025, 4:24pm

By Ryan Scott

Article

The first patient with relapsed or refractory acute myeloid leukemia has been dosed with Annamycin plus Cytarabine in the global phase 3 MIRACLE trial.

Second-Line Tovecimig Elicits Responses in Biliary Tract Cancer

April 1st 2025, 3:00pm

By Alex Biese

Article

Treatment with tovecimig, formerly known as CTX-009, elicited responses in patients with biliary tract cancer, according to COMPANION-002 study results.

Tagrisso May Improve Survival in Advanced EGFR-Mutant NSCLC

April 1st 2025, 1:13pm

By Alex Biese

Article

Tagrisso is associated with positive outcomes among patients with unresectable stage 3 EGFR-mutant non-small cell lung cancer.

Metastatic Kidney Cancer Requires a Multidisciplinary Approach to Care

March 31st 2025, 9:00pm

By Dr. William C. Huang

Video

CURE spoke with Dr. William C. Huang about what kind of team may be required to treat a patient with metastatic kidney cancer.

COCOON Trial Regimen Reduces Dermatologic Side Effects in Mutated Lung Cancer

March 31st 2025, 8:00pm

By Spencer Feldman

Article

The COCOON trial regimen reduced dermatologic side effects in patients with EGFR-mutant non-small cell lung cancer, phase 2 trial data showed.

First-line Rybrevant Combo Extends Survival in Advanced Lung Cancer

March 31st 2025, 7:00pm

By Ryan Scott

Article

First-line Rybrevant plus Lazcluze significantly extended overall survival versus Tagrisso in mutated, advanced or metastatic non-small cell lung cancer.

The Positivity Trap of Follicular Lymphoma and Cancer

March 31st 2025, 5:00pm

By Karen Cohn

Article

As a lymphoma survivor, I struggle with the positivity trap — sometimes, I just want my fears validated instead of being reassured everything is fine.

Patient With Head and Neck Cancer Dosed in Trial of APR-1051

March 31st 2025, 4:02pm

By Alex Biese

Article

A patient with HPV-positive head and neck squamous cell carcinoma was dosed in a phase 1 clinical trial evaluating APR-1051.

Relacorilant Plus Chemo Meets Primary Goal in Ovarian Cancer Trial

March 31st 2025, 3:29pm

By Spencer Feldman

Article

The phase 3 trial showed relacorilant with chemotherapy improved progression-free and overall survival in platinum-resistant ovarian cancer.

Inside the Mind of a Bile Duct Cancer Survivor

March 31st 2025, 1:00pm

By Lisa Craine

Article

I’ve spent 14 years navigating recovery, mental health challenges and giving back to the cancer community through patient mentorship.